ASA orders Relx and Louis Shaw to stop promoting e-cigarettes on Instagram

Market by The Drum

Jun.29.2022

The ASA concluded that it breached the Cap Code (Edition 12) 2.1, 2.3 and 22.12.

The UK’s Advertising Standards Authority (ASA) has directed Chinese e-cigarette brand Relx and Geordie Shore star Louis Shaw to stop promoting nicotine-containing e-cigarettes on Instagram.

In December 2021 an Instagram story on Shaw’s account showed a hand holding two boxes containing unlicensed e-cigarettes with the brand name RELX, with text stating: ‘@RELXUK’ and ‘GET YOUR OWN – RELAX WITH 15% OFF – LOUISXMAS15.’ This 15% discount code for the product was considered promotional by the ASA.

ASA orders Relx and Louis Shaw to stop promoting e-cigarettes on Instagram — *ASA directs Relx and Louis Shaw to not promote e-cigarettes on Instagram in future*

The ad also featured text saying, ‘This product contains nicotine, which is a highly addictive substance.’

The ASA concluded that it breached the Cap Code (Edition 12) 2.1, 2.3 and 22.12.

The post was investigated on two grounds:

The complainant challenged whether the ad did not make clear its commercial intent

The ASA challenged whether the ad breached the code by promoting unlicensed, nicotine-containing e-cigarettes and their components on Instagram

Also read:

RELX Vapes Seized by Regulator Possibly due to Incomplete Docs

#E-cigarette #E-cigarettes and Tobacco #RELX Technology

Glas, the FDA, and the Future of Flavored ENDS

China Tobacco Regulation Shift：Policy Updates and Market Impact

Australian Border Force: Illegal tobacco and vaping products worth A$1 billion in tax revenue gap intercepted in Q2 2025

Australian Border Force intercepts over $1 billion worth of illegal tobacco and e-cigarettes, totaling 467+ tons. Leading enforcement against smuggling.

Feb.05 by 2FIRSTS.ai

Philippine Tobacco Control Coalition Backs Raising Legal Age for Vape and Tobacco Products to 25

A coalition of health and child rights advocates in the Philippines said it supports Health Secretary Teodoro Herbosa’s call to raise the legal age restriction for vape and tobacco products from 18 to 25. The group said scientific evidence shows that the brain of a young person continues to develop until the mid-20s, and that nicotine exposure during that period can cause lasting impairment in impulse control, learning, and mood regulation.

Mar.11 by 2FIRSTS.ai

Indonesian vape retailers’ association tells members to halt sales to under-21 customers

The Indonesian Vape Retailers Association (Arvindo) has instructed all member stores to stop selling electronic cigarettes to customers under 21. Arvindo said it issued an official circular requiring vape shops to display 21+ signage and to ask customers for valid identification.

Feb.26

Russian consumer group urges Kremlin administration to reject regional vape sales bans

A Russian consumer organization has urged the Presidential Administration to block proposals that would let regions ban ENDS and e-liquid sales, warning it would create fragmented regulation and turbocharge the illicit market. The group cites WHO statistics and overseas experiences to argue for a more targeted regulatory model.

Feb.06 by 2FIRSTS.ai

IQOS UK unveils 2026 pop-up events plan, first stops set for London and three other cities

IQOS’ UK website shows the company will roll out time-limited pop-up experience spaces across Britain in 2026 for adult consumers. The first confirmed locations are London, the West Midlands area near Birmingham, Manchester and Romford, offering product demonstrations, pop-up-only promotions and nicotine pouch sampling. Entry will be restricted to those aged 18 and over, with “Challenge 25” ID checks in place.

Feb.03 by 2FIRSTS.ai

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.

Special Report

Mar.03